🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
WHW
$WHWK
🔒 US EquitiesWhitehawk Therapeutics Inc
AVG HISTORICAL GAP
+0.14%
MAX GAP RECORD
-3.70%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $WHWK
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$WHWK
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN) |
+0.49%
|
| May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN) |
-0.24%
|
| Mar 12, 2026 Earnings Release 2026-03-12 (BEFORE OPEN) |
+0.00%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (UNDETERMINED) |
+0.00%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN) |
-2.22%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+1.84%
|
| Mar 17, 2025 Earnings Release 2025-03-17 (AFTER CLOSE) |
+2.38%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.8%
Bullish Gaps (4)
Bearish Gaps (3)
Neutral / Flat (2)
📖 Intelligence Summary
Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗